Key signaling pathways such as TGF-β, Wnt/β-catenin, and Notch are recognized as major regulators of EMT, with their aberrant activation contributing to colorectal cancer metastasis and drug resistance (30–33). The gene discussed is TGFB1; the disease is colorectal cancer.